Immediate Impact
1 by Nobel laureates 2 from Science/Nature 51 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Works of Eve Gallop‐Evans being referenced
Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression
2018
Guidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphoma
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Eve Gallop‐Evans | 579 | 239 | 358 | 256 | 27 | 845 | |
| Alden A. Moccia | 737 | 197 | 453 | 250 | 39 | 819 | |
| Henning Bredenfeld | 545 | 128 | 370 | 212 | 22 | 814 | |
| Olivier Fitoussi | 593 | 206 | 463 | 185 | 42 | 845 | |
| Lisa Lowry | 617 | 153 | 467 | 224 | 19 | 740 | |
| F. Morschhauser | 673 | 176 | 440 | 162 | 26 | 918 | |
| Niels Murawski | 697 | 289 | 474 | 336 | 38 | 936 | |
| Alessia Bari | 540 | 172 | 441 | 145 | 53 | 884 | |
| Fiona Miall | 555 | 289 | 423 | 142 | 32 | 725 | |
| U. Rueffer | 561 | 146 | 374 | 249 | 14 | 737 | |
| Paul‐André Bryon | 501 | 259 | 339 | 145 | 18 | 676 |
All Works
Loading papers...